DN.9693, a phosphodiesterase inhibitor, compared with prostaglandin E1 and prostacyclin in four platelet "function" tests.
O'Brien
J R
JR
Central Laboratory, St. Mary's Hospital, Portsmouth, Hants., England.
Etherington
M D
MD
Salmon
G P
GP
D015105:3',5'-Cyclic-AMP Phosphodiesterases / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D000527:Alprostadil / Q000494:pharmacology*; D003018:Clot Retraction; D011464:Epoprostenol / Q000494:pharmacology*; D006801:Humans; D010974:Platelet Aggregation / Q000187:drug effects; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology*; D010979:Platelet Function Tests; D011799:Quinazolines / Q000494:pharmacology*
D010975:Platelet Aggregation Inhibitors; D011799:Quinazolines; C049662:1,5-dihydro-7-(1-piperidinyl)-imidazo(2,1-b)quinazolin-2(3H)-one; D011464:Epoprostenol; D015105:3',5'-Cyclic-AMP Phosphodiesterases; D000527:Alprostadil